Table 11 Utility parameters
Health state | QALY | Source / Comment |
|---|---|---|
Progression free survival (RFS) | 0.875 (Treatment independent) | Gerbasi et.al [40]., Table 3 based on a post-hoc analysis of individual patient EQ-5D data in study CombiAD [32] |
Progression locoregional | 0.875 | Based on Gerbasi et.al [40]., Table 3 |
Progression distant metastases 1st line treatment | 0.724 | Based on Gerbasi et.al [40]., Table 3 |
Progression distant metastasis, 2nd line treatment | 0.653 | Based on Gerbasi et.al [40]., Table 3 |